0001562180-21-000933.txt : 20210205
0001562180-21-000933.hdr.sgml : 20210205
20210205162219
ACCESSION NUMBER: 0001562180-21-000933
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210205
DATE AS OF CHANGE: 20210205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karydas Daphne
CENTRAL INDEX KEY: 0001816952
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 21595705
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-02-03
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001816952
Karydas Daphne
35 GATEHOUSE DRIVE
BUILDING D, FLOOR 3
WALTHAM
MA
02451
false
true
false
false
Chief Financial Officer
Stock Option (Right to Buy)
21.36
2021-02-03
4
A
false
95000.00
0.00
A
2031-02-03
Common Stock
95000.00
95000.00
D
1/48th of the shares subject to the option shall vest monthly over a four-year period.
/s/ Michael A. Metzger, Attorney-in-Fact
2021-02-05